Immediate Impact
1 from Science/Nature 64 standout
Citing Papers
Targeted protein degradation: from mechanisms to clinic
2024 Standout
Chimeric antigen receptor T cell therapy for autoimmune disease
2024 Standout
Works of Chikako Ohwada being referenced
Sustained Immunogenic and Clinical Effects of Low-Dose Interleukin-2 Therapy with an Intermittent Maintenance Method for Refractory Chronic Graft-Versus-Host Disease: Results of Phase1/2a LDIL2-01 Study
2020
Phase I/IIa Study of Low Dose Subcutaneous Interleukin-2 (IL-2) for Treatment of Refractory Chronic Graft Versus Host Disease.
2016
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Chikako Ohwada | 339 | 144 | 70 | 141 | 62 | 658 | |
| Emiko Sakaida | 353 | 154 | 51 | 138 | 103 | 820 | |
| Masahiro Takeuchi | 233 | 120 | 138 | 96 | 66 | 837 | |
| Yvonne Loh | 226 | 84 | 144 | 130 | 32 | 594 | |
| Dina Attias | 197 | 73 | 205 | 211 | 46 | 843 | |
| Hiroshi Moritake | 293 | 63 | 99 | 105 | 79 | 842 | |
| Sigal Grisariu | 229 | 211 | 80 | 172 | 46 | 708 | |
| Alexander Kulagin | 287 | 44 | 323 | 218 | 118 | 730 | |
| Monika Maas Enriquez | 422 | 80 | 48 | 99 | 31 | 635 | |
| D. Harms | 164 | 124 | 36 | 89 | 41 | 696 | |
| O. Decaux | 140 | 48 | 40 | 99 | 45 | 680 |
All Works
Login with ORCID to disown or claim papers
Loading papers...